AU2001237438A1 - Potassium channel protein kcnq5, a target for diseases of central nervous systemand cardiovascular system - Google Patents
Potassium channel protein kcnq5, a target for diseases of central nervous systemand cardiovascular systemInfo
- Publication number
- AU2001237438A1 AU2001237438A1 AU2001237438A AU3743801A AU2001237438A1 AU 2001237438 A1 AU2001237438 A1 AU 2001237438A1 AU 2001237438 A AU2001237438 A AU 2001237438A AU 3743801 A AU3743801 A AU 3743801A AU 2001237438 A1 AU2001237438 A1 AU 2001237438A1
- Authority
- AU
- Australia
- Prior art keywords
- kcnq5
- potassium channel
- activity
- systemand
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004257 Potassium Channel Human genes 0.000 title 1
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 108020001213 potassium channel Proteins 0.000 title 1
- 101000994656 Homo sapiens Potassium voltage-gated channel subfamily KQT member 5 Proteins 0.000 abstract 4
- 102100034365 Potassium voltage-gated channel subfamily KQT member 5 Human genes 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010001497 Agitation Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 210000004413 cardiac myocyte Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10013732 | 2000-03-21 | ||
| DE10013732A DE10013732A1 (de) | 2000-03-21 | 2000-03-21 | Das Kaliumkanalprotein KCNQ5, ein neuer Angriffspunkt bei Erkrankungen des zentralen Nervensystems und des Herz-Kreislauf-Systems |
| PCT/EP2001/002791 WO2001070811A1 (en) | 2000-03-21 | 2001-03-13 | Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001237438A1 true AU2001237438A1 (en) | 2001-10-03 |
Family
ID=7635606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001237438A Abandoned AU2001237438A1 (en) | 2000-03-21 | 2001-03-13 | Potassium channel protein kcnq5, a target for diseases of central nervous systemand cardiovascular system |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1268545B1 (enExample) |
| JP (1) | JP5622345B2 (enExample) |
| AT (1) | ATE336508T1 (enExample) |
| AU (1) | AU2001237438A1 (enExample) |
| DE (2) | DE10013732A1 (enExample) |
| WO (1) | WO2001070811A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002543768A (ja) * | 1999-04-14 | 2002-12-24 | メルク エンド カムパニー インコーポレーテッド | 新規ヒト電位依存性カリウムチャンネル |
| US6649371B1 (en) | 1999-06-11 | 2003-11-18 | Neurosearch A/S | Potassium channel KCNQ5 and sequences encoding the same |
| CA2410489A1 (en) * | 2000-05-26 | 2001-12-06 | Bristol-Myers Squibb Company | Human kcnq5 potassium channel, methods and compositions thereof |
| DE10342022A1 (de) | 2003-09-11 | 2005-04-07 | Voith Paper Patent Gmbh | Aufwickelvorrichtung |
| US7517960B2 (en) | 2006-01-19 | 2009-04-14 | Wyeth | Rat KCNQ5 voltage-gated potassium channel |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE356200T1 (de) * | 1997-08-12 | 2007-03-15 | Bristol Myers Squibb Co | Kcnq kaliumkanäle und verfahren zur deren modulierung |
| JP4520634B2 (ja) * | 1997-10-24 | 2010-08-11 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション | 良性の家族性新生児痙攣（ｂｆｎｃ）および他の癲癇において突然変異されたｋｃｎｑ２およびｋｃｎｑ３−カリウムチャンネル遺伝子 |
| GB9726339D0 (en) * | 1997-12-13 | 1998-02-11 | Zeneca Ltd | Human-derived tissue-specific potassium channel |
| AU2092700A (en) * | 1999-01-26 | 2000-08-18 | Neurosearch A/S | Novel potassium channels and genes encoding these potassium channels |
| JP2002543768A (ja) * | 1999-04-14 | 2002-12-24 | メルク エンド カムパニー インコーポレーテッド | 新規ヒト電位依存性カリウムチャンネル |
| JP4833467B2 (ja) * | 1999-06-11 | 2011-12-07 | ニューロサーチ、アクティーゼルスカブ | 新規カリウムチャネル及び同カリウムチャネルをコードする遺伝子 |
-
2000
- 2000-03-21 DE DE10013732A patent/DE10013732A1/de not_active Withdrawn
-
2001
- 2001-03-13 JP JP2001569011A patent/JP5622345B2/ja not_active Expired - Fee Related
- 2001-03-13 EP EP01909831A patent/EP1268545B1/en not_active Expired - Lifetime
- 2001-03-13 AT AT01909831T patent/ATE336508T1/de not_active IP Right Cessation
- 2001-03-13 WO PCT/EP2001/002791 patent/WO2001070811A1/en not_active Ceased
- 2001-03-13 DE DE60122301T patent/DE60122301T2/de not_active Expired - Lifetime
- 2001-03-13 AU AU2001237438A patent/AU2001237438A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1268545A1 (en) | 2003-01-02 |
| JP5622345B2 (ja) | 2014-11-12 |
| DE60122301D1 (de) | 2006-09-28 |
| DE60122301T2 (de) | 2007-09-13 |
| EP1268545B1 (en) | 2006-08-16 |
| JP2004512009A (ja) | 2004-04-22 |
| WO2001070811A1 (en) | 2001-09-27 |
| DE10013732A1 (de) | 2001-09-27 |
| ATE336508T1 (de) | 2006-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0994190A3 (en) | DNA conferring L-homoserine resistance to bacteria, and its use | |
| ATE389666T1 (de) | Hohe expressionsrate von proteinen | |
| WO2003027266A3 (en) | Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof | |
| ATE310015T1 (de) | Hohe expressionsrate des grün-fluoreszierenden proteins | |
| BR9813608B1 (pt) | célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase. | |
| IL118201A0 (en) | Erythropoietin free of animal proteins processes for production and use thereof | |
| CA2180103A1 (en) | Gene encoding adseverin | |
| ATE310098T1 (de) | Dna kodierend für glutaminsäure-gesteuerte chloridkanäle | |
| WO2004053059A3 (en) | Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same | |
| CA2260365A1 (en) | Differentiation-suppressive polypeptide | |
| AU3802595A (en) | Tripeptidyl aminopeptidase | |
| WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
| DE60313866D1 (de) | Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür | |
| NZ527971A (en) | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon | |
| EP0723017A3 (de) | Transketolase | |
| WO1997039721A3 (en) | Methods and compositions for regulating t cell subsets by modulating transcription factor activity | |
| AU2001237438A1 (en) | Potassium channel protein kcnq5, a target for diseases of central nervous systemand cardiovascular system | |
| WO2002066636A3 (en) | T cell receptor variants expressed in mesenchymal cells and uses thereof | |
| WO1995000552B1 (en) | Prostaglandin receptor ep3 and dna encoding it | |
| AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
| AU7896700A (en) | Methods to identify compounds that modulate neuronal activity | |
| WO1999058648A3 (en) | Guava (psidium guajava) 13-hydroperoxide lyase and uses thereof | |
| ATE406446T1 (de) | Vermehrungsproteine von pflanzen | |
| WO1999063081A3 (en) | Ion channels | |
| MXPA03011260A (es) | Receptor acoplado a proteina g y usos del mismo. |